
Many of these CDMO optimizations fail because:
If the performance of your CDMO is not where it should be, you are surely already familiar with the symptoms:
And in many companies, despite multiple attempts, there is no truly fundamental change.
That is not unusual!
In the pharmaceutical industry, CMO and CDMO optimizations do not fail because people do not know what needs to be done, but often because no one consistently takes care of implementation or is in a position to do so.
The optimization of contract manufacturers is usually about costs and cost structures. In addition, it is also about reliability, quality and delivery capability, as well as:
And of course, in addition, about GMP topics that affect both customers and suppliers.
If you are responsible for these areas:
then such failures are not only of theoretical interest to them! If these improvement projects do not work, they usually have to deal with troubleshooting because this then leads to delays, budget overruns, and consequently internal pressure.
Most organizations already understand:
The problem is not the understanding, but the implementation and execution under real GMP conditions.
Brief digression: even AI won't change that. It's not the written texts or presentations that are missing, it's the implementation in reality!
How do you improve CDMO management?
The optimization of contract manufacturers usually falls under the responsibility of various departments, such as:
These various departments all handle specific aspects of the collaboration with the contract manufacturer. But responsibility remains fragmented and usually results in:
What works well according to our experience instead is:
important rule:
Without overall responsibility, there is no optimization, only coordination. Coordination alone produces no results.
The optimization of contract manufacturers usually falls under the responsibility of various departments, such as:
Many initiatives miss their mark because they remain at a very theoretical level:
However, to achieve tangible improvements, it would require:
Cause: usually there is an external consulting firm behind it that focuses mainly on strategy
Impact: No change whatsoever in day-to-day operations
Solution: applied and practical implementation in the organization
Contract manufacturers improve through operational changes and not through PowerPoint presentations!
Optimization for contract manufacturers requires mastering real-world challenges (and not just theoretical discussions)
Without practical experience:
Many initiatives miss their mark because they remain at a very theoretical level:
Many initiatives miss their mark because they remain at a very theoretical level:
A biotech startup is trying to improve the performance of its contract manufacturers through a global consulting firm:
Situation: unreliable deliveries, high deviations and delays
Actions: Strategy workshop and process design (textbook)
Result: no measurable improvement after six months
Only through pragmatic implementation together with the contract manufacturer:
why this vote is critical:
Typical problem cases include, among others:
simple problems recur without being sustainably resolved
changes are happening very slowly or not at all
a high degree of frustration on both sides
Â
clearly agree on the goals in the form of KPIs (sounds completely trivial, but is often not done)
give the joint projects a fixed structure with fixed responsibilities
Define escalations and how to discuss and resolve them in advance
Why are pharmaceutical supply chains becoming unstable?
This complex of causes is very closely connected to the involvement of large consulting firms and often occurs together:
improvement initiatives often invent new tools and processes:
new reporting tools (always with an Excel pie chart!)
Additional processes
complex reporting processes with new metrics derived from many other metrics (making it very difficult to assess whether changes will have a positive or negative impact on these metrics)
what happens as a result:
The team does not want to use these new tools and finds shortcuts or excuses
The entire implementation is getting slower and slower
Every change must be discussed again and again, over and over
what really works is:
Many of these problems can be quickly stabilized if the operational bottlenecks are clearly identified.
Real workflows are only rarely the way they are on paper or depicted in a flowchart. Take the trouble to trace actual work packages as they are actually processed.
The problems often lie in the fact that:
The resulting threats are then:
So the problem is:
The change process does not end with the publication of the document. This is only where it begins! It is often necessary to make changes after a few months. For this, it is important that all participants continue to be informed about the status and the implementation.
If the parties involved are not kept informed, it often happens that:
What really works is:
Simple communications on how the applied improvement methods function and operate
Show progress
Prepare the participants from the very beginning for the fact that changes will be coming after a few months.
How to better control CMOs?
Many organizations lean back as soon as the associated documents and contracts are signed and published internally.
Many structures lack:
Clear success goals that are understood in the exact same way by both sides
Structured performance reviews that take place regularly (not just a mandatory year-end review)
Active management of the supplier-customer relationship
Result if this is not done:
what works are:
How do you reduce risks in pharmaceutical supply chains?
By that I don't mean a risk management document, but the consideration of what to actually do in the event of a problem.
The optimization of a supplier involves these three major risk areas:
How do you improve CDMO management?
Many project failures happen due to risk problems rather than strategy problems
Important experiences from many projects
many failures result from poor execution rather than a flawed strategy
clear responsibility, that „taking care of things“ is probably the most important success factor
Strategy without an implementation plan and execution yields no results.
practical implementation beats theoretical consulting

Dr Georg Astl is the founder of Eoswiss Pharma. He is the author of numerous specialized articles and a speaker at professional events.